U.S. Digital Pathology Market Size & Outlook, 2023-2030
U.S. digital pathology market, 2018-2030 (US$M)
Related Markets
U.S. digital pathology market highlights
- The U.S. digital pathology market generated a revenue of USD 338.1 million in 2023 and is expected to reach USD 546.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, device was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
| Market revenue in 2023 | USD 338.1 million |
| Market revenue in 2030 | USD 546.8 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Device |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Device, Storage Systems |
| Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.8% of the global digital pathology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. digital pathology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 131.4 million by 2030.
Device was the largest segment with a revenue share of 52.17% in 2023. Horizon Databook has segmented the U.S. digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of well-established healthcare infrastructure & high per capita healthcare expenditure in the U.S is a major factor contributing to the high adoption rate of advanced digital pathology systems. The U.S. healthcare expenditure increased by 4.6% in 2018 to USD 3.6 trillion or USD 11,172 per person and is expected to remain high in the near future.
The approval of the AI powered tool designed by AI-based, digital pathology-focused companies to identify invasive breast cancer and skin lesions is another factor boosting the market growth in the region.
In addition, local presence of major industry leaders in this region contributes to the market growth through development of innovative digital pathology systems. In addition, key players in this market have a strong network of technology distributors in the U.S., which is expected to boost market growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Pathology Market Scope
Digital Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. digital pathology market size, by product, 2018-2030 (US$M)
U.S. Digital Pathology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
